THE TRANSFORMATION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE SN-38 BY HUMAN LIVER-MICROSOMES - DIFFERENTIAL HYDROLYSIS FOR THE LACTONE AND CARBOXYLATE FORMS
Mc. Haaz et al., THE TRANSFORMATION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE SN-38 BY HUMAN LIVER-MICROSOMES - DIFFERENTIAL HYDROLYSIS FOR THE LACTONE AND CARBOXYLATE FORMS, Naunyn-Schmiedeberg's archives of pharmacology, 356(2), 1997, pp. 257-262
Irinotecan (CPT-11) is a new camptothecine derivative presently in dev
elopment for the treatment of several advanced malignancies. It is con
verted in vivo to a highly potent metabolite, SN-38, by carboxylestera
ses. All camptothecine derivatives undergo lactonolysis in a pi-I-depe
ndent reversible manner, generating inactive carboxylate forms. We hav
e investigated in vitro the kinetics of transformation of CPT-11 to SN
-38 by human liver microsomes originating from several donors. Microso
mes from seven livers were studied individually or as a pooled prepara
tion. CPT-11, either in its lactone or its carboxylate form, was added
at a range of concentrations. The SN-38 formed was measured by HPLC w
ith fluorometric detection. In the deacylation-limited carboxylesteras
e reaction, the linear steady-state kinetics between 10 and 60 min wer
e determined. At all concentrations of CPT-11, the steady-state veloci
ty of SN-38 formation as well as the intercept concentrations of SN-38
were about 2-fold higher when the substrate was under the lactone for
m than under the carboxylate form. We estimated the values (+/-SD) of
K'(m), and V-max to be 23.3+/-5.3 mu M and 1.43+/-0.15 pmol/min/mg for
the lactone and 48.9+/-5.5 mu M and 1.09+/-0.06 pmol/min/mg for the c
arboxylate form of CPT-11, respectively. We conclude that the greater
rate of conversion of CPT-11 lactone may contribute to the plasma pred
ominance of SN-38 lactone observed in vivo. The inter-individual varia
tion of SN-38 formation was relatively high (ratio of 4 between extrem
e values) but no large age- or gender-related differences were seen. T
he effect of twelve drugs of different therapeutic classes (antibiotic
s, antiemetics, antineoplastics, antidiarrhoeics, analgesics), which c
ould be administered in association with irinotecan in the clinical se
tting, was evaluated in this system (drug concentration: 100 mu M; CPT
-11 lactone concentration: 10 mu M). Loperamide and ciprofloxacine whe
re the only drugs exerting a weak inhibition of CPT-11 conversion to S
N-38.